Clinic Nuclear Medicine PET Scan 
Imaging Technology
APRIL 24, 2024
The findings were published in Clinical Nuclear Medicine. The newly published study involved performing PET scans on 22 people with MS and eight healthy controls. Those being treated with low-efficacy treatments had more abnormalities on their PET scans, suggesting more microglial cell activation.
AuntMinnie
APRIL 29, 2024
In a study published April 17 in Clinical Nuclear Medicine , the group at Brigham tested a new TSPO radiotracer they developed for visualizing such activity called F-18 PBR06. The researchers performed F-18 PBR06 PET scans on 22 patients with MS and eight healthy controls.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JUNE 19, 2024
PET imaging shows different brain activity in people taking methadone or buprenorphine for opioid use disorder (OUD), according to a presentation at the recent Society of Nuclear Medicine and Molecular Imaging annual meeting. They tracked serum levels of methadone or buprenorphine for the OUD subjects.
AuntMinnie
MARCH 26, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. The nuclear radiologist, nuclear medicine technologist, and radiation safety team are all present to administer an infusion.
Imaging Technology
FEBRUARY 9, 2024
milla1cf Fri, 02/09/2024 - 09:17 February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before clinical symptoms arise, according to research published in the February issue of The Journal of Nuclear Medicine.
AuntMinnie
MARCH 6, 2024
Dynamic PET scans acquired in half the time of normal scans appear clinically feasible for patients with lung lesions, according to nuclear medicine researchers in Shenzhen, China. A 60-year-old male patient with clinical suspicion of lung cancer. The article was published March 5 in EJNMMI Physics.
AuntMinnie
OCTOBER 27, 2023
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Research suggests that the accumulation of these proteins is a continuous process that starts decades before the onset of symptoms.
Expert insights. Personalized for you.
102 
Let's personalize your content